James Coulston's most recent trade in ProKidney Corp - Ordinary Shares - Class A was a trade of 650,000 Employee stock option (right to buy) done . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProKidney Corp - Ordinary ... | James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 650,000 | 650,000 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 275,000 | 275,000 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 290,000 | 290,000 | - | - | Employee stock option, right to buy | |
| ProKidney Corp - Ordinary ... | James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 325,170 | 325,170 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 716,850 | 716,850 | - | - | Class B Ordinary Shares | |
| ProKidney Corp - Ordinary ... | James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 716,850 | 716,850 | - | - | Common Units in ProKidney LP |